Seres Therapeutics, Inc. (MCRB) Revenue Growth
Seres Therapeutics, Inc. (MCRB) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 47.48% |
| 2018-12-31 | -16.15% |
| 2019-12-31 | 1.01% |
| 2020-12-31 | -56.24% |
| 2021-12-31 | 1109.19% |
| 2022-12-31 | -95.05% |
| 2023-12-31 | 1672.24% |
| 2024-12-31 | N/A |
| 2025-12-31 | N/A |
How MCRB compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc. | 370.22% |
| INMB | INmune Bio Inc. | 257.14% |
| ALT | Altimmune Inc. | 105.00% |
| NVAX | Novavax Inc. | 64.69% |
| LXRX | Lexicon Pharmaceuticals Inc. | 60.24% |
These are five companies in the same sector as MCRB with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Seres Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("MCRB", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | MCRB | $5.72 | +1.42% | 0.04M |
| 3 | ||||
| 4 | ||||
| 5 |